ACTILYSE 50mg placebo, ACTILYSE, poudre et solvant pour solution injectable et perfusion
P160924
Phase 3 small_molecule active
Quick answer
ACTILYSE 50mg placebo, ACTILYSE, poudre et solvant pour solution injectable et perfusion for intermediate-high-risk acute pulmonary embolism is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- intermediate-high-risk acute pulmonary embolism
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active